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HOW COMPETENT ARE PEOPLE WHO USE OPIOIDS AT RESPONDING TO 
OVERDOSES? QUALITATIVE ANALYSES OF ACTIONS AND DECISIONS TAKEN 
BY LAY FIRST-RESPONDERS DURING OVERDOSE EMERGENCIES 
 
 
ABSTRACT  
Background and aims: Providing take-home naloxone (THN) to people who use opioids is an 
increasingly common strategy for reversing opioid overdose. However, implementation is 
hindered by doubts regarding the ability of people who use opioids to administer naloxone and 
respond appropriately to overdoses. We aimed to increase understanding of the competencies 
required and demonstrated by opioid users who had recently participated in a THN program and 
were subsequently confronted with an overdose emergency. 
Design: Qualitative study designed to supplement findings from a randomized controlled trial of 
overdose education and naloxone distribution. Interviews were audio-recorded, transcribed, 
systematically coded, and analyzed via Iterative Categorization. 
Setting: New York City, USA. 
Participants: 39 people who used opioids (32 men, 7 women; ages 22-58 years). 
Intervention: Trial participants received brief or extended overdose training and injectable or 
nasal naloxone. 
Measurements: The systematic coding frame comprised deductive codes based on the topic guide 
and more inductive codes emerging from the data. 
Findings: In 38/39 cases the victim was successfully resuscitated; the outcome of one overdose 
intervention was unknown. Analyses revealed five core overdose response ‘tasks’: 1. Overdose 
identification; 2. Mobilizing support; 3. Following basic first aid instructions; 4. Naloxone 
administration; and 5. Post-resuscitation management. These tasks comprised actions and 
decisions that were themselves affected by diverse cognitive, emotional, experiential, interpersonal 
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and social factors over which lay first-responders often had little control. Despite this, participants 
demonstrated high levels of competency. They had acquired new skills and knowledge through 
training and brought critical ‘insider’ understanding to overdose events and the resuscitation 
actions which they applied.  
Conclusions: People who use opioids can be trained to respond appropriately to opioid overdoses 
and thus to save their peers’ lives. Overdose response requires both practical competency (e.g. 
skills and knowledge in administering basic first aid and naloxone) and social competency (e.g. 
willingness to help others, having the confidence to be authoritative and make decisions, 
communicating effectively, and demonstrating compassion and care to victims post-resuscitation).  
 
 
KEYWORDS  
 
OVERDOSE; NALOXONE; TAKE-HOME NALOXONE; OVER-ANTAGONSIM; CARDIO 
PULMONARY RESUSCITATION; COMPETENCY; TRAINING; QUALITATIVE  
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HOW COMPETENT ARE PEOPLE WHO USE OPIOIDS AT RESPONDING TO 
OVERDOSES? QUALITATIVE ANALYSES OF ACTIONS AND DECISIONS TAKEN 
BY LAY FIRST-RESPONDERS DURING OVERDOSE EMERGENCIES 
 
 
INTRODUCTION 
 
More than 100,000 opioid overdose deaths occur globally per annum.[1] In the United States (U.S.), 
there were 63,632 overdose deaths in 2016, of which 42,249 were attributable to prescription or 
illicit opioids.[2] Drug overdose deaths more than tripled between 1999 and 2016, and the rate 
continues to increase.[2,3] Timely administration of the opioid antagonist naloxone can reverse 
respiratory depression related to opioid overdose, preventing fatalities.[4] Naloxone has been used 
in emergency settings for many years[5,6] and is now available to non-medically trained people, 
including people who use opioids, their friends and family.[7-9] Naloxone pre-provision, with 
instruction on management of the overdose crisis while awaiting emergency medical care, is 
known as take-home naloxone (THN).   
 
THN programs exist in many countries, including the United States.[8,10,11] Programs are supported 
by World Health Organization guidelines[12] and endorsed by the United Nations.[13] Evidence 
suggests that providing people who use opioids with overdose training increases their knowledge 
of overdose risk factors, signs, and responses[14-19], that people who use opioids can and will use 
naloxone to reverse overdoses when trained[18,20-22], and that naloxone distribution to people who 
use opioids reduces mortality[23,24] and is cost-effective.[25,26] Despite this, most countries do not 
have naloxone programs and countries that do have programs have differing policies, training and 
provision that can be constrained by national and local legal and regulatory frameworks, as well 
as costs.[27,28] For example, naloxone ampoules for intramuscular or multi-step atomized nasal 
administration are currently cheaper and more widely provided internationally than the new single-
step purpose-designed concentrated naloxone nasal sprays now entering the U.S., Australian and 
European markets.[8] 
 
Other factors impeding THN implementation have been reported and include negative public 
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attitudes and the stigma associated with opioid consumption, which can discourage professionals 
from providing, and users from requesting, naloxone.[28-30] There have also been reports that people 
who use opioids are not able to recognize and respond to overdoses reliably[29-34] and may be 
reluctant to administer naloxone because they are anxious about police involvement, needle stick 
injuries, being too intoxicated, or intervening when a victim does not want help.[30,35] Research has 
additionally indicated that peers trained in overdose response may continue to use non-evidence-
based strategies alongside recommended strategies[18,21,36] and that they may be deterred from 
using naloxone because it can prompt withdrawal symptoms which make victims aggressive 
(‘over-antagonism’).[37] Furthermore, studies have suggested that THN might reduce ambulance 
call-outs resulting in fatalities from the recurrence of respiratory depression if lay first-responders 
leave victims unattended[18,38-40]; although this has also been refuted.[15,41,42]  
 
Given these uncertainties, we need to know more about how opioid users who are trained in 
naloxone actually react when an overdose event occurs. This is vital to inform the planning and 
provision of effective THN, particularly as new naloxone formulations and delivery systems are 
developed, laws expanding naloxone access are passed, and interventions to safeguard individuals 
from certain criminal sanctions if they report an overdose ‘in good faith’ (known in the U.S. as 
Good Samaritan Laws) are increasingly implemented.[43] With few exceptions[35,44-46], information 
on how people who use opioids respond when they witness an overdose derives from quantitative 
studies which provide limited insights into how and why specific actions were taken.[20,33,39,47-50] 
This paper draws upon detailed first-hand accounts of how opioid users who had recently 
participated in a THN program responded when confronted with an overdose emergency. By 
systematically analyzing their actions and decisions, we aim to increase understanding of the 
competencies required and demonstrated.  
 
 
METHODS 
 
We designed a qualitative study to supplement findings from a randomized controlled trial of 
overdose education and naloxone prescribing to individuals with opioid use disorder. Both the 
qualitative study and the trial received ethical approval from the New York State Psychiatric 
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Institute (NYSPI) Institutional Review Board (IRB# 6723) and were conducted in New York City, 
where a Good Samaritan Law had been in operation since 2011. Trial participants received brief 
or extended overdose training and injectable or nasal naloxone. Brief training typically took 20-30 
minutes and included overdose risk factors (e.g. mixing drugs), how to recognize an opioid 
overdose (e.g. blue lips or nail beds) and a demonstration on how to use naloxone. Extended 
training comprised the brief training plus an additional two-hour session that reiterated and 
reinforced key information from the brief training, provided further information about non-opioid 
overdose, and taught cardio pulmonary resuscitation. Both the brief and extended training were 
conducted at Columbia University Medical Center by one of two research assistants who followed 
a manual/written script to ensure every participant received exactly the same information (see Box 
1 for additional trial details).  
 
BOX 1 
 
Between January 2016 and October 2017, 45 trial participants reported being present at an 
overdose and they all expressed interest in completing an optional qualitative interview. All 45 
were consequently provided with additional information on the interview process and given an 
interview date and time. Five (4 men; 1 woman) did not attend on the day; the other 40 (33 men; 
7 women) undertook further consent procedures and were then interviewed in private offices at 
the NYSPI by members of the research team who were trained in qualitative interviewing 
(A.N.C.C, J.D.J., V.E.M.). Interviews were semi-structured, audio-recorded, lasted 20-65 minutes, 
and followed a topic guide that covered: demographic and psychosocial information, substance 
use and treatment, pre-trial overdoses experienced and witnessed, the last overdose witnessed since 
joining the trial, and views on overdose training. Core questions relating to the last overdose 
witnessed are shown in Box 2. These were supplemented by prompts and probes to ascertain 
further details. Participants were compensated $40.  
 
BOX 2 
 
Interviews were transcribed verbatim and the encrypted anonymized transcriptions were emailed 
to the research team in London. Here they were entered into MAXQDA v11[51] for systematic 
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coding. The coding frame comprised deductive codes based on the topic guide and more inductive 
codes emerging from the data. For consistency, one member of the team (C.B.) coded all data and 
the process was checked by J.N. To meet the aims of this paper, all data coded to eight codes 
relating to the last overdose witnessed were analyzed (Box 3).  
 
BOX 3 
 
The coded data were first exported into eight Microsoft Word documents and each Word document 
was inductively analyzed via Iterative Categorization.[52] This generated patterns and themes 
relating to participants’ actions and decisions. As the patterns and themes overlapped across the 
documents, all findings were merged into one document and the patterns and themes were re-
organized and re-grouped. This yielded five core overdose response tasks, now informed by 
accounts of how and why participants had responded as they had. Analyses were undertaken by 
J.N. and discussed with other team members.  
 
 
Participants 
 
Data from 39 of the 40 participants (32 men, 7 women; ages 22-58 years) were analyzed. One 
participant was excluded as he had experienced, rather than witnessed, an overdose. The 39 
included participants had a recent history of heroin use and 14 were current injectors. Nineteen 
reported that they had ever overdosed themselves. Most interviews were conducted within 2 
months of the witnessed overdose (range 1 day to 6 months) and victims included partners, 
relatives, friends, acquaintances and strangers. Thirty-six participants administered naloxone (31 
used a multi-step atomized nasal spray; 5 used intramuscular naloxone) and 29 called the 
emergency services. In 38/39 cases the victim was successfully resuscitated; the outcome of one 
overdose was unknown as the participant administered nasal naloxone but then left as soon as the 
emergency services arrived. Additional participant and overdose reversal details are shown in 
Table 1. 
 
TABLE 1 
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FINDINGS 
 
The core overdose response tasks identified during the analyses were: 1. Overdose identification; 
2. Mobilizing support; 3. Following basic first aid instructions; 4. Naloxone administration; and 5. 
Post-resuscitation management. These are described below, illustrated by quotations labelled with 
the participant’s qualitative study identifier and sex. 
 
 
Task 1: Overdose identification 
 
Participants generally reported that they had been alerted to an overdose on either hearing a 
bystander call for help or seeing somebody staggering, falling over, or lying on the ground. Very 
few participants described hesitating before investigating further. One woman said that she had 
not known the victim so was initially unsure about whether to get involved and one man reported 
wavering because he was worried he might be evicted from the shelter where he was living if the 
shelter staff realized he was using drugs. In contrast, most participants explained that they had 
immediately rushed over to the incident or had observed the situation for a few moments before 
intervening: 
 
“His friend was… hitting him and he would not wake up… I was watching him hit him... 
I was like, ‘Dude, he’s really fucking wrecked’. That’s when I went over.” (#11 female)  
 
Several participants emphasized that they were keen to intervene in any emergency as they wanted 
to help others. For example, one woman said she always looked for people overdosing, one man 
said that he had been looking forward to saving a life since joining the trial, and another man said 
he would always intervene as that is just ‘the type of person’ he is:  
 
“Just because of the type of person I am… I always carry my kit [naloxone].” (#30 male) 
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Whilst some participants stressed that they could instantly recognize an opioid overdose as they 
had seen so many previously, others acknowledged that they had found it difficult to tell if the 
victim was overdosing or just heavily intoxicated, particularly if they did not know the victim, 
what they had used, their tolerance, or their usual behavior. Some participants reported that they 
had suspected an overdose based on the victim’s demeanor (e.g. snoring, not responsive), the 
location (e.g. toilet, stairwell, known drug spot) or other circumstantial factors (e.g. person taking 
‘too long’ in the bathroom, the victim or others present were known heroin users, fentanyl in the 
area). Participants then described additional signs that confirmed their assessment; e.g. the victim 
was changing colour, had blue lips or small pupils, was ‘foaming’ at the mouth, remained 
unresponsive after being slapped, was breathing shallowly or not at all, or was behaving oddly. 
Evidence of drugs (e.g. tourniquet, needle, track marks, drugs lying around) provided additional 
corroborating evidence: 
 
“Being around that area, I figured it was an overdose… It was a men’s bathroom, so I just 
went in to check. As I opened the stall door it was a guy sitting there with a needle stuck in 
his arm and he was passed out. So I immediately knew it was an overdose because he was 
foaming out the mouth and he was snoring real loud.” (#16 male) 
 
Having decided that an overdose had occurred, participants occasionally reflected on what drugs 
had likely been taken and what might have been the cause so that they could respond effectively 
or pass this information to the emergency services. To this end, participants questioned the victim, 
drew their own conclusions based on their knowledge of the victim or their assessment of the 
scene, or asked others present for details: 
 
“I asked, ‘How long she been there? What happened?’ They [bystanders] said, ‘She ain’t 
been in that long’... They knew she was an IV [intravenous] user.” (#28 female) 
 
 
Task 2: Mobilizing support  
 
Once an overdose had been confirmed, participants frequently described how they had taken 
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charge of the situation (e.g. instructing others to fetch their naloxone, call the emergency services 
or reposition the victim). Sometimes participants justified their authority by telling others that they 
had completed training and so were ‘qualified’. One participant explained that he had taken control 
because his friend was panicking: 
 
“He [friend] was just panicking, like, ‘Oh my God, dude, what’s going on?’ Like ‘Is he 
alright?’ Like ‘Call the police’. And I was like, ‘Well alright, we’re going to call the police, 
but let me just do this first because I’m trained in this.’ And I just administered the first 
dose [naloxone].” (#36 male)  
 
Additionally, several participants described working in conjunction with other bystanders to 
resuscitate the victim. These bystanders included friends or relatives of the victim or the 
participant, other substance users, shelter workers, security guards, and passersby:  
 
“We [participant and bystander] were working together… I gave her [victim] the nasal 
[naloxone] and we just kept on performing [cardio pulmonary resuscitation]. And she 
[bystander doing chest compressions] was tiring, but she kept on. We started, did the mouth 
[rescue breathing] until the ambulance got there.” (#6 male) 
 
Participants often reported that they had called 911 (the emergency services), or told somebody 
else to call 911, as soon as they had realized there was a medical emergency. Others stated that 
they had called 911 just before, or immediately after, they had given naloxone, and two reported 
that they had phoned 911 whilst administering naloxone. Participants gave three main reasons for 
calling 911: they had been told to do this in their training; they felt they needed professional 
support in case the victim died; and they were worried that the victim might go back into the 
overdose if they did not receive medical attention after naloxone was administered.  
 
Sometimes, however, participants said that they had not called 911 because the victim had told 
them not to; they believed they had the situation under control; or they were afraid of ‘getting into 
trouble’, ‘having their name written down by the authorities’, being arrested, being imprisoned, 
being evicted from their shelter, or drawing unwanted attention to themselves:  
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“I would have called them [911] if I couldn’t have woken him up. But… I knew he was 
gonna be alright once I gave him that stuff [naloxone]… If I thought that he was really at 
risk of anything I would’ve definitely called the ambulance.” (#30 male) 
 
Countering these concerns, several participants were confident that, according to the training they 
had received, the police could not take any action against them for administering naloxone or for 
being present at an overdose, particularly if they showed their overdose training identification card. 
 
 
Task 3: Following basic first aid instructions 
 
Participants routinely explained that they had tried hard to follow the first aid instructions they had 
been given in their training. A few said that they had felt confident and prepared, that their training 
had ‘just kicked in’, or that they had instinctively known what to do, particularly if they had 
successfully resuscitated someone previously:  
 
“Stuff that I’ve learned in the past... It’s just one of those things where you know what it 
is, and you know how to do it.” (#33 male)  
 
Others stated that they had felt anxious but had still remembered what they had been taught. Some, 
however, confessed that they had frozen or panicked. In consequence, they said that they had 
forgotten aspects of the training or were uncertain whether they had done things ‘correctly’ or in 
the right order. Despite this, most reported that they had first tried to wake the victim, usually by 
shouting or slapping them hard, commonly across the face. Others had shaken the victim in a more 
controlled way or performed a sternum rub. Only a few participants said that they had used cold 
water or ice to shock the victims awake. Meanwhile, several reflected on techniques they had 
previously used (e.g. injecting salt or giving victims milk or oil to drink), noting that they would 
no longer use these after learning of their ineffectiveness during their training: 
 
“I was gonna tell him to give him milk. I said, ‘Wait a minute. I got the Narcan 
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[naloxone]… that will snap him out of it’.” (#35 male) 
 
Participants generally reported that they had also checked the victim’s breathing. For this, they 
had used a range of techniques, e.g. listening; looking for the rise and fall of victim’s chest; placing 
a hand over the victim’s nose and mouth; or using their phone screen, cellophane wrapping from 
a cigarette packet or a compact mirror to look for signs of breath via condensation: 
 
“I put my phone under his nose before I took him off the toilet… there was really nothing, 
no condensation on the phone.” (#18 male) 
 
Less commonly, participants described checking the victim’s pulse, performing chest 
compressions, giving rescue breaths or placing the victim in the recovery position. Some 
participants reported that they had not performed mouth-to-mouth as the victim was still breathing. 
Others explained that they would not initiate rescue breathing because the victim had ‘foam’ 
coming from their mouth, they did not want their lips to ‘touch others’ lips’, or they were anxious 
about AIDS. Several participants also explained that they had been worried about performing chest 
compressions as they did not feel adequately trained. Furthermore, administering naloxone was 
described as easier and more essential than other first aid stages: 
 
“I didn’t try to give her no mouth-to-mouth… I thought it was best to just go ahead and just 
do it [naloxone] right away. See what happened.” (#28 female) 
 
 
Task 4: Naloxone administration 
 
Participants sometimes explained that it had taken them a few minutes to remember that they had 
naloxone and could use it. Administration was then further delayed if participants had to return to 
their home, shelter room, or car to retrieve it. Others had their naloxone with them in a bag or 
pocket but did not use it immediately. Instead, they consciously considered whether and, if so 
when, administration would be appropriate. Occasionally, participants said that they had hesitated 
because they had felt uncertain or nervous. Indeed, one participant said he was so anxious that he 
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had given his naloxone to a bystander to administer: 
 
“I just bring the thing [naloxone] to him [bystander]. I said ‘Yo, if you need this, you just 
got to put it in his nose and he gonna wake up’.” (#20 male) 
 
More commonly, participants explained that they had been reticent to give naloxone as it could 
prompt the victim to experience withdrawal symptoms and the victim would then be angry on 
regaining consciousness. Reflecting this, a few participants emphasized that they would not give 
naloxone unless it was essential, and the victim was unresponsive, not breathing, blue, or likely to 
die. In contrast, others rationalized that they might as well give naloxone as they had been told in 
the training that it could do no harm. Furthermore, two participants had felt confident enough to 
administer naloxone even though professionals (a 911 operator and shelter worker respectively) 
had advised them against this: 
 
“When we called 911… they said, ‘Don’t do anything’. And I’m like, ‘Well… if I’m up 
on somebody and I have naloxone and they need it… if they look like they’re dying, I’m 
going to help them’.” (#7 female) 
 
Having resolved to administer naloxone, participants recounted how they then had to decide where 
and how to position the victim. This could involve carrying them from a bathroom, moving them 
from a shelter, lying them flat, or propping them up. Repositioning was complicated if a victim 
still had a needle in their arm as this then had to be removed invoking fears of a needle stick injury. 
If victims were heavy or awkwardly positioned, participants sometimes needed others to physically 
help them. Compounding these practical difficulties, several participants reported that they had 
struggled to assemble their nasal naloxone kit:  
 
“I actually forgot how to put it together… They have the instructions on the bag... I read 
the instructions and now I’m… kinda freakin out. I get it together and I give her the shot.” 
(#17 male) 
 
Mostly, participants explained that they had followed what they had been told in the training about 
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giving half a dose of nasal naloxone in each nostril and then waiting before re-dosing. If the first 
dose did not revive the victim, participants usually said that they had administered a second dose. 
However, there was considerable variability in the length of time participants left between doses 
(0 to 15 minutes). Even when participants remembered that they had been told to wait between 
doses, they often gave the second dose immediately because the victim did not regain 
consciousness instantly and that worried them. Sometimes, a second or third dose was given (‘to 
be on the safe side’) even though the victim had already regained consciousness:  
 
“She was breathing, but it was very, very labored, so that’s why I administered the second 
one [dose]. Because she didn’t come out of it with the first one.” (#33 male)  
 
Occasionally, participants rationalized that the victim needed two doses of nasal naloxone because 
they had used a large quantity of drugs, and a few stated that if the victim became angry because 
they went into withdrawal, that would ‘just be too bad’.  
 
 
Task 5: Post-resuscitation victim management  
 
Participants often described how the victim had been confused, disorientated, frightened or angry 
on regaining consciousness. In response, they had mostly told the victim what had happened, even 
though they had anticipated that the victim would be angry because the naloxone would have 
‘taken away their high’, ‘wasted their drugs’, and potentially ‘put them into withdrawal’. 
Accordingly, information on naloxone administration was imparted sensitively to the victim and 
often with reassurance that they would soon feel alright, but they must not use more drugs in case 
they overdosed again. Furthermore, they should now receive professional medical attention. 
Participants also sometimes used this moment to ascertain more information from the victim about 
who they were and what had happened, or to give the victim general advice (e.g. about seeking 
treatment or not using drugs alone in the future): 
 
“I said, ‘You, in a couple hours, two maybe three hours, that Narcan is gonna wear out and 
you’re gonna be in that same position where you was at when I gave it to you’. I said, ‘You 
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won’t be OD’ing but you gonna be very, very high. So, if you don’t want to go to the 
hospital, don’t get high’.” (#35 male)  
 
Although most participants seemed to recognize if the victim was experiencing withdrawal 
symptoms, several said that the victim was sweating or vomiting and they did not know why (a 
few attributed vomiting to fentanyl in the drugs taken). Sometimes participants disposed of leftover 
drugs or withheld them from the victim in case they tried to take more. However, on a few 
occasions, participants – who said that they understood the pain of withdrawal symptoms – had 
provided the victim with more opioids a few hours later to help them manage their symptoms. For 
example, one female participant gave her husband a bag of heroin without which she said he would 
have been too unwell to travel to his treatment program, and a male participant took drugs to the 
hospital after the victim had pleaded with him for something to help until he received his prescribed 
methadone: 
  
“About two hours later, he called me and begged me, like, ‘Bro, you have no idea. These 
people not going to get me methadone until tomorrow. I’m fucking dying…’ I know… that 
desperation. Like you’ll fucking rob the doctor’s computer if you have to… The bags [of 
drugs] that I had found, I kept them… then I brought him one. He kind of relaxed.” (#19 
male) 
  
Whilst most participants reported that they had stayed with the victim as they were recovering, a 
small number left as soon as they were certain the victim was alright, or the emergency 
services/ambulance had arrived. These participants tended to be anxious about the police arriving 
or were worried that the victim might get aggressive if they went into withdrawal. Participants 
who stayed generally reported that they had told emergency service personnel everything they 
could about what had happened. Nonetheless, a few said that they had refused to give out details, 
preferring to tell officials as little as possible. Often, participants explained that the victim had 
been reluctant, or had refused, to wait for the ambulance. Nonetheless, some had successfully 
persuaded victims to attend hospital for further assessment. Occasionally, the participant had gone 
with the victim in the ambulance or visited them later (even if the victim was a stranger) to check 
they were safe:  
AUTHOR ACCEPTED COPY. ADDICTION. NOVEMBER 2018 
 
 17 
 
“When he seen them [emergency services personnel] walk through the door, he was like, 
‘No, no, no. I don’t need them’… I said, ‘Listen… You’re going with them. I’ll go with 
you, but you’re going.’ And he went with the flow. He allowed that.” (#18 male) 
 
 
DISCUSSION 
 
Competence can be defined as the relationship between people’s abilities or capabilities and the 
satisfactory completion of appropriate task(s).[53] We identified 5 core overdose response tasks, 
each requiring actions and decisions. These actions and decisions were in turn affected by: i. 
cognitive ability (e.g. to recognize the signs of overdose and remember the training received); ii. 
emotional reactions (e.g. panic, nerves, fear of the victim dying, anxiety about getting into trouble 
with the authorities despite the local Good Samaritan Law, revulsion at giving rescue breaths); iii. 
prior personal experiences (e.g. previous witnessed or experienced overdoses which increased 
confidence in recognizing and responding); iv interpersonal relationships (e.g. knowledge of the 
victim, respecting the victim’s wishes not to call 911, wanting to reassure, care for and advise the 
victim); and v. situation (e.g. who else was present to assist, where the overdose occurred, whether 
naloxone was close to hand).  
 
Our findings thus show that the ability to act ‘competently’ in an overdose emergency is influenced 
by myriad factors over which a lay first responder may have little direct control. This more 
complex, and less ‘agentic’, view of competency resonates with a recent shift in health education 
towards the concept of ‘structural competency’.[54] Structural competency recognizes that medical 
problems and their treatment (in this case opioid overdose and its response) cannot be divorced 
from a priori social, political and economic forces that contribute to ill-health and poor health 
choices. Stigma, criminalization, homelessness, and lack of education are all implicated in drug 
problems[55-58], but also impede an individual’s ability to respond effectively to drug overdose.[58,59] 
Participants routinely overcame these hurdles to be ‘good citizens’, ‘take charge’, provide advice, 
behave in a caring way, and ultimately save lives.[see also 46] This is consistent with wider 
international evidence that people who use opioids are responsible and capable individuals who 
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routinely deliver interventions (including mutual aid, recovery enterprises, and harm reduction 
initiatives) to help their peers.[60]  
 
Furthermore, the analyses undertaken have revealed how people who use opioids bring critical 
‘insider’ knowledge and understanding (‘competency by experience’) to overdose events. This 
includes their ability to rapidly assess a scene for signs and symptoms of overdose, anticipate and 
empathize with a victim’s withdrawal symptoms, withhold or titrate a naloxone dose depending 
on the drugs likely taken, communicate effectively with a confused victim, and persuade a reluctant 
patient to accept professional medical care. Additionally, participants demonstrated how they had 
acquired new skills and knowledge from their training, were willing to prioritize this new formal 
knowledge above non-evidence-based strategies they had used in the past[contrary to 21], and felt 
empowered by their ability to respond.[36,44,61,62]  
 
This is not to suggest that participants did not make errors or questionable judgments. Some 
panicked, forgot tasks or completed them in a random order, struggled to assemble the nasal 
naloxone kit, administered more naloxone than was probably necessary, left the scene at the 
earliest opportunity, and refused to communicate with emergency services personnel or other 
officials. Nonetheless, actions and decisions that might have appeared ‘incompetent’, 
‘irresponsible’ or even ‘wrong’ (e.g. administering naloxone against professional advice, 
managing an overdose without calling the emergency services, or providing additional opioids to 
counter over-antagonism) merit closer inspection. It is possible that participants were 
demonstrating high levels of competency (administering naloxone completely appropriately, 
avoiding a genuinely unnecessary ambulance call out, or protecting somebody from totally 
avoidable painful withdrawals). If similar actions and decisions had been made by a medical 
professional, we might regard them as demonstrating confidence, knowledge and skill. 
 
Opioid users who have personally responded to an overdose have valuable insights and experience 
and can play an important role in delivering THN programs because they can help their peers 
understand what actually happens and how lay first-responders feel during and after an overdose 
event. Notably, two participants successfully administered naloxone contrary to professional 
advice and another took drugs to a hospitalized victim because hospital staff would not provide 
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methadone to ease his withdrawals until the following day. Professionals working in health and 
social care-related services (including 911 operators and shelter staff) also have overdose training 
needs and might similarly benefit from training that incorporates the first-hand accounts of people 
who have witnessed overdose emergencies. Furthermore, hospital-based harm reduction 
interventions that acknowledge the subjective health needs and experiences of people who use 
drugs (e.g. the provision of rescue opioids in the event of naloxone over-antagonism or rapid access 
to opioid assisted treatment) might increase post overdose hospital attendance and retention, 
promote patient-centred care, and ultimately reduce adverse health outcomes.[37,63] 
 
 
Limitations and strengths 
 
We successfully interviewed 40/45 (89%) trial participants who reported being present at an 
overdose and 39/44 (89%) trial participants who had witnessed an overdose during their time in 
the trial. Nonetheless, it is possible that the 40 individuals who were interviewed were more likely 
to believe they had acted responsibly and appropriately, and were therefore more willing to speak 
about their actions and experiences, than the 5 who were not interviewed. Equally, there may have 
been other trial participants who did not report that they had been present at an overdose because 
they had not intervened, had left a victim without calling the emergency services, or had acted 
unsuccessfully. Our qualitative study may thus have failed to access information on people who 
did not demonstrate competency despite their training. This does not invalidate our findings, but 
reminds us not to draw any empirical generalizations from the analyses presented. 
 
In addition, most participants were men and most used a multi-step atomized nasal spray. 
Consequently, we are unable to analyze the data by gender or type of naloxone used. New purpose-
designed nasal sprays, which do not generate the difficulties some participants identified in 
assembling the multi-step devices, are now available in the U.S.[64] However, both the cheaper 
injectable formulations and the cheaper improvised nasal kits are likely to be used internationally 
for years to come. The data presented therefore retain currency despite recent technological 
advances in naloxone provision. Also, we have not considered how the training received (brief or 
extended) influenced competency as this will be reported separately once the RCT is complete. As 
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previously stated, the aim of this paper was to better understand competency; not measure it. A 
key strength of our analyses is that all data were collected within six months, and sometimes a few 
days, of an overdose occurring, so generating uniquely detailed accounts of what actually 
happened and why. 
 
 
CONCLUSIONS 
 
Analyses of the actions and decisions taken during recently witnessed overdoses have provided 
insights into exactly how opioid users who had been trained in THN responded when confronted 
with a medical emergency. We identified five core overdose response tasks: 1. Overdose 
identification; 2. Mobilizing support; 3. Following basic first aid instructions; 4. Naloxone 
administration; and 5. Post-resuscitation management. Our findings suggest that responding to 
overdose events requires both practical competency (e.g. skills and knowledge in administering 
first aid and naloxone) and social competency (e.g. willingness to help others, having the 
confidence to be authoritative and make decisions, communicating effectively with all present, and 
demonstrating compassion and care to victims post resuscitation).[see also 46] People who use opioids 
are routinely stigmatized and associated with incapacity and the harms they cause.[55,65-68] The data 
presented counter such perceptions by demonstrating how they can be skillful, knowledgeable and 
caring, as well as willing and able to save lives.[see also 46,58,62] 
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BOXES AND TABLES 
 
Box 1: Trial details and study context 
 
Name: Risk and benefits of overdose education and naloxone prescribing to heroin users 
Dates: September 2014 – August 2019 
Funder: National Institute on Drug Abuse: R01DA035207 
Principal Investigator: Sandra D. Comer, Ph.D. 
Primary Aim: To determine the extent to which more extensive overdose education may 
improve overdose outcomes compared to brief overdose education. 
Recruitment criteria: Male or female 21-65 years of age; meet DSM-5 criteria for opioid use 
disorder within the past 6 months regardless of current treatment status; speak/read English; no 
active psychiatric disorder that might interfere with participation; no naloxone or cardio 
pulmonary resuscitation training within past 2 years. 
Trial context: New York City (NYC), NY, USA. Mirroring national trends, overdose rates in 
NYC continue to rise. NYC formalized overdose education and naloxone distribution in 2006. 
In 2011, NYC introduced a Good Samaritan Law providing a limited shield from charge and 
prosecution when emergency services are notified of a potential overdose event. 
Types of training received by trial participants: Prior to receiving naloxone in NYC, individuals 
must complete brief overdose training which addresses overdose risk factors, how to recognize 
an opioid overdose and how to use naloxone. Participants in the trial received this brief training 
or extended training. Extended training comprised the brief training plus an additional two-hour 
session that reiterated and reinforced key information from the brief training, provided 
additional information about non-opioid overdose, and taught cardio pulmonary resuscitation. 
Type of naloxone available to trial participants: At the start of the trial, participants were 
offered the choice of an intramuscular naloxone formulation (1 mL naloxone vial + syringe [3 
cc/mL, 22G]) or a multi-step atomized nasal naloxone spray (2mg/2 mL Luer-Jet™ Luer-Lock 
needleless naloxone syringe plus mucosal atomizer device [MAD-300]). In 2015, the U.S. Food 
and Drug Administration approved a single-step nasal naloxone formulation (NARCAN® 
NASAL SPRAY). Although participants subsequently recruited to the trial were offered the 
single-step formulation, the qualitative study participants were all recruited before the single-
step formulation was available.  
Clinicaltrials.gov: NCT02535494 
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Box 2: Core questions relating to the last overdose 
 
i. What happened? 
ii. How was the overdose was recognized? 
iii. Who made the decisions? 
iv. Was cardio pulmonary resuscitation (CPR) performed? 
v. Was naloxone given? 
vi. Were the emergency services called? 
vii. What happened after the overdose? 
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Box 3: Codes analysed 
 
i. What happened at the last overdose 
ii. Recognizing the last overdose  
iii. Deciding what to do at the last overdose 
iv. Cardio pulmonary resuscitation at the last overdose 
v. Naloxone administration at the last overdose 
vi. Calling the emergency services at the last overdose 
vii. Non-evidence-based responses at the last overdose 
viii. Other aspects of the last overdose 
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Table 1: Participant and overdose information* 
 
 
Characteristic Participant 
Gender  
   Male 32 
   Female 7 
Age (years)  
   Mean (range) 45 (22-58) 
Ethnicity  
   Hispanic/Latino  15 
   Black/African American  14 
   White American  8 
   Asian  1 
   Mixed Race  1 
Current injector  
   Yes 14 
   No 25 
Had personally experienced an overdose prior to joining the trial  
   Yes 19 
   No 15 
   Missing 5 
Had witnessed an overdose prior to joining the trial  
   Yes 34 
   No 4 
  Missing 1 
Type of naloxone administered at the last witnessed overdose  
   Intranasal (multi-step atomized nasal spray) 31 
   Intramuscular 5 
   None** 3 
Emergency services called at the last witnessed overdose  
   Yes 29 
   No 10 
Victim survived the last witnessed overdose  
   Yes 38 
   Unknown as participant left once the emergency services arrived*** 1 
* The type of training participants received (brief or extended) is blinded to the research team to preserve the integrity 
of the trial analyses. 
** One participant gave rescue breaths which revived the victim until the emergency services arrived and took over; 
one participant did not have his naloxone with him so called a security guard and asked them to phone for an 
ambulance; and one participant called the emergency services because he was anxious about going into the shelter 
where he lived to collect his naloxone in case staff evicted him for using substances. 
*** On balance it seems likely that the victim survived as the participant reported that they had given one dose of 
nasal naloxone and the victim had momentarily come out of the overdose but then went back into the overdose just 
before the emergency services arrived. 
 
 
 
 
